Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5292]

New tumour spatial mapping tool will help clinicians assess aggressiveness of cancer and personalise treatment

New tumour spatial mapping tool will help clinicians assess aggressiveness of cancer and personalise treatment

Cancer centre develops first individualised predictive model for multiple myeloma treatment

Cancer centre develops first individualised predictive model for multiple myeloma treatment

Clues to cancer drug’s deadly side effects could make it safer

Clues to cancer drug’s deadly side effects could make it safer

Study shows clinical benefit of new way of treating advanced ER+ breast cancer

Study shows clinical benefit of new way of treating advanced ER+ breast cancer

Novel treatment regimen for FLT3-Mutated acute myeloid leukaemia shows promise

Novel treatment regimen for FLT3-Mutated acute myeloid leukaemia shows promise

Evaluation of ruxolitinib, a Janus Kinase inhibitor, in multiple myeloma

Evaluation of ruxolitinib, a Janus Kinase inhibitor, in multiple myeloma

PROX1/α-SMA correlated with colorectal cancer progression, poor outcomes and therapeutic resistance

PROX1/α-SMA correlated with colorectal cancer progression, poor outcomes and therapeutic resistance

Lung cancer hijacks immune cell metabolism to fuel its own growth

Lung cancer hijacks immune cell metabolism to fuel its own growth

SORA combined with FGF21 can inhibit the growth and promote apoptosis of HCC cells through Smad3

SORA combined with FGF21 can inhibit the growth and promote apoptosis of HCC cells through Smad3

Immune networks in tumours prime responses to a personalised immunotherapy

Immune networks in tumours prime responses to a personalised immunotherapy

More from ecancer